Skip to Content
You are currently on the new version of our website. Access the old version .

433 Results Found

  • Perspective
  • Open Access
17 Citations
5,752 Views
11 Pages

Mechanisms of Rhinovirus Neutralisation by Antibodies

  • Lila Touabi,
  • Faryal Aflatouni and
  • Gary R. McLean

25 February 2021

Antibodies are a critical immune correlate of protection for rhinoviruses, particularly those antibodies found in the secretory compartment. For nonenveloped viruses such as rhinoviruses, antibody binding to regions of the icosahedral capsid can neut...

(This article belongs to the Special Issue Rhinovirus Infections)
  • Article
  • Open Access
13 Citations
5,969 Views
12 Pages

Cross-Neutralisation of Novel Bombali Virus by Ebola Virus Antibodies and Convalescent Plasma Using an Optimised Pseudotype-Based Neutralisation Assay

  • Emma M. Bentley,
  • Samuel Richardson,
  • Mariliza Derveni,
  • Pramila Rijal and ,
  • Alain R. Townsend,
  • Jonathan L. Heeney,
  • Giada Mattiuzzo and
  • Edward Wright
  • + 3 authors+ 0 author

Ebolaviruses continue to pose a significant outbreak threat, and while Ebola virus (EBOV)-specific vaccines and antivirals have been licensed, efforts to develop candidates offering broad species cross-protection are continuing. The use of pseudotype...

(This article belongs to the Section Infectious Diseases)
  • Article
  • Open Access
29 Citations
7,243 Views
18 Pages

18 October 2016

There is limited information on the cross-neutralisation of neurotoxic venoms with antivenoms. Cross-neutralisation of the in vitro neurotoxicity of four Asian and four Australian snake venoms, four post-synaptic neurotoxins (α-bungarotoxin, α-elapit...

(This article belongs to the Section Animal Venoms)
  • Article
  • Open Access
28 Citations
9,618 Views
14 Pages

19 June 2015

The present research aimed to investigate the decision-making process for sustainable holidays, as a type of ethical consumption related to environmental welfare. Using semi-structured in-depth interviews with 20 German holidaymakers of different age...

(This article belongs to the Special Issue Challenges for Marketers in Sustainable Production and Consumption)
  • Article
  • Open Access
8 Citations
3,050 Views
14 Pages

Over 32,000 individuals succumb to snake envenoming in sub-Saharan Africa (sSA) annually. This results from several factors, including a lack of antivenom products capable of neutralising the venoms of diverse snake species in this region. Most manuf...

(This article belongs to the Section Molecular Biology)
  • Article
  • Open Access
1,712 Views
24 Pages

Characterisation of Naturally Occurring MERS-CoV Spike Mutations and Their Impact on Fusion and Neutralisation

  • Rachael Dempsey,
  • Hannah Goldswain,
  • Joseph Newman,
  • Nazia Thakur and ,
  • Tracy MacGill,
  • Todd Myers,
  • Robert Orr,
  • Dalan Bailey,
  • James P. Stewart and
  • Julian A. Hiscox
  • + 6 authors+ 1 author

18 March 2026

In this study, the phenotypic consequences of naturally occurring single nucleotide polymorphisms (SNPs) in the Middle East respiratory syndrome coronavirus (MERS-CoV) Spike protein were investigated. The impact of Spike mutations on the syncytia for...

(This article belongs to the Section Coronaviruses)
  • Article
  • Open Access
9 Citations
3,618 Views
14 Pages

Development of Viral-Vectored Vaccines and Virus Replicon Particle-Based Neutralisation Assay against Mayaro Virus

  • Young Chan Kim,
  • Arlen-Celina Lücke,
  • César López-Camacho,
  • Beate Mareike Kümmerer and
  • Arturo Reyes-Sandoval

Mayaro virus (MAYV) is an emerging alphavirus causing acute febrile illness associated with chronic polyarthralgia. Although MAYV is currently restricted to tropical regions in South America around the Amazon basin, it has the potential to spread glo...

(This article belongs to the Special Issue Antivirals and Vaccines)
  • Brief Report
  • Open Access
30 Citations
3,166 Views
8 Pages

Improved Neutralisation of the SARS-CoV-2 Omicron Variant following a Booster Dose of Pfizer-BioNTech (BNT162b2) COVID-19 Vaccine

  • Kerri Basile,
  • Rebecca J. Rockett,
  • Kenneth McPhie,
  • Michael Fennell and ,
  • Jessica Johnson-Mackinnon,
  • Jessica E. Agius,
  • Winkie Fong,
  • Hossinur Rahman,
  • Danny Ko and
  • Jen Kok
  • + 14 authors+ 9 authors

13 September 2022

In late November 2021, the World Health Organization declared the SARS-CoV-2 lineage B.1.1.529 the fifth variant of concern, Omicron. This variant has acquired over 30 mutations in the spike protein (with 15 in the receptor-binding domain), raising c...

(This article belongs to the Section SARS-CoV-2 and COVID-19)
  • Article
  • Open Access
1,102 Views
11 Pages

27 October 2025

Effective disinfectant validation is essential for ensuring biosafety in high-containment laboratories when lethal pathogens are being handled. Micro-Chem Plus™ (MCP) is widely used in high-containment facilities for pathogen disinfection and r...

(This article belongs to the Section Human Virology and Viral Diseases)
  • Article
  • Open Access
2 Citations
1,460 Views
14 Pages

Geographical Differences in SARS-CoV-2 Antibody Response Dynamics and Neutralisation Profiles to Mild COVID-19: Lessons from a UK–Uganda Comparison

  • Laban Kato,
  • Jackson Sembera,
  • Gerald Kevin Oluka,
  • Joseph Ssebwana Katende and ,
  • Juliana Bemanzi,
  • Violet Ankunda,
  • Peter Ejou,
  • Ashwini Kurshan,
  • Carl Graham and
  • Jennifer Serwanga
  • + 10 authors+ 5 authors

21 March 2025

Background: The global SARS-CoV-2 pandemic revealed stark variability in clinical outcomes across populations, underscoring the need for region-tailored vaccination strategies. To inform standardised global immunisation efforts, this study compared l...

(This article belongs to the Section COVID-19 Vaccines and Vaccination)
  • Article
  • Open Access
10 Citations
3,489 Views
10 Pages

With the dynamic development of renewable energies, energy storage devices, and electric vehicles, microgrids have been playing an increasingly vital role in smart power grids. Under the recent development of carbon neutralisation, microgrid systems...

(This article belongs to the Topic Zero Carbon Vehicles and Power Generation)
  • Article
  • Open Access
6 Citations
1,793 Views
13 Pages

Neutralisation of the Immunoglobulin-Cleaving Activity of Streptococcus equi Subspecies equi IdeE by Blood Sera from Ponies Vaccinated with a Multicomponent Protein Vaccine

  • Francesco Righetti,
  • Karina Hentrich,
  • Margareta Flock,
  • Sara Frosth and ,
  • Karin Jacobsson,
  • Joakim Bjerketorp,
  • Anuj Pathak,
  • Noela Ido,
  • Birgitta Henriques-Normark and
  • Andrew Stephen Waller
  • + 10 authors+ 5 authors

17 October 2025

Background: Streptococcus equi subspecies equi (S. equi) is the cause of strangles, one of the most prevalent diseases of horses worldwide. The disease is characterised by fever and the formation of abscesses in the lymph nodes of the head and n...

(This article belongs to the Special Issue Animal Diseases: Immune Response and Vaccines)
  • Article
  • Open Access
29 Citations
8,473 Views
18 Pages

Pan-American Lancehead Pit-Vipers: Coagulotoxic Venom Effects and Antivenom Neutralisation of Bothrops asper and B. atrox Geographical Variants

  • Lachlan A. Bourke,
  • Christina N. Zdenek,
  • Edgar Neri-Castro,
  • Melisa Bénard-Valle and ,
  • Alejandro Alagón,
  • José María Gutiérrez,
  • Eladio F. Sanchez,
  • Matt Aldridge and
  • Bryan G. Fry
  • + 4 authors+ 0 author

22 January 2021

The toxin composition of snake venoms and, thus, their functional activity, can vary between and within species. Intraspecific venom variation across a species’ geographic range is a major concern for antivenom treatment of envenomations, parti...

(This article belongs to the Special Issue Interactions of Snake Venoms and Antivenoms: Prelude to Protection)
  • Article
  • Open Access
11 Citations
3,078 Views
11 Pages

Omicron Sub-Lineage BA.5 and Recombinant XBB Evasion from Antibody Neutralisation in BNT162b2 Vaccine Recipients

  • Martina Brandolini,
  • Giulia Gatti,
  • Laura Grumiro,
  • Silvia Zannoli and ,
  • Valentina Arfilli,
  • Monica Cricca,
  • Giorgio Dirani,
  • Agnese Denicolò,
  • Maria Michela Marino and
  • Vittorio Sambri
  • + 9 authors+ 4 authors

The recent emergence of a number of new SARS-CoV-2 variants resulting from recombination between two distinct parental lineages or sub-lineages within the same lineage has sparked the debate regarding potential enhanced viral infectivity and immune e...

(This article belongs to the Special Issue COVID-19/SARS-CoV-2: Infection, Vaccination and Immune Response)
  • Article
  • Open Access
5 Citations
2,686 Views
16 Pages

Surrogate Virus Neutralisation Test Based on Nanoluciferase-Tagged Antigens to Quantify Inhibitory Antibodies against SARS-CoV-2 and Characterise Omicron-Specific Reactivity in a Vaccination Cohort

  • Michael Schoefbaenker,
  • Rieke Neddermeyer,
  • Theresa Guenther,
  • Marlin M. Mueller and ,
  • Marie-Luise Romberg,
  • Nica Classen,
  • Marc T. Hennies,
  • Eike R. Hrincius,
  • Stephan Ludwig and
  • Eva U. Lorentzen
  • + 6 authors+ 1 author

8 December 2023

Virus-specific antibodies are crucial for protective immunity against SARS-CoV-2. Assessing functional antibodies through conventional or pseudotyped virus neutralisation tests (pVNT) requires high biosafety levels. Alternatively, the virus-free surr...

(This article belongs to the Section COVID-19 Vaccines and Vaccination)
  • Article
  • Open Access
321 Views
19 Pages

12 September 2026

The rapid decarbonisation of urban districts is accelerating the deployment of rooftop photovoltaic (PV) systems, household battery energy storage systems (BESSs) and electric vehicles (EVs). However, the high variability of urban micro-generation cr...

(This article belongs to the Special Issue Social Risks and Urban Governance in Low-Carbon Energy Transformation)
  • Review
  • Open Access
14 Citations
7,913 Views
26 Pages

Filovirus Neutralising Antibodies: Mechanisms of Action and Therapeutic Application

  • Alexander Hargreaves,
  • Caolann Brady,
  • Jack Mellors,
  • Tom Tipton and ,
  • Miles W. Carroll and
  • Stephanie Longet
  • + 1 author+ 0 author

16 September 2021

Filoviruses, especially Ebola virus, cause sporadic outbreaks of viral haemorrhagic fever with very high case fatality rates in Africa. The 2013–2016 Ebola epidemic in West Africa provided large survivor cohorts spurring a large number of human studi...

(This article belongs to the Special Issue Characterization of Antibody Responses to Virus Infections in Humans)
  • Brief Report
  • Open Access
6 Citations
4,392 Views
7 Pages

Prevalence of Neutralising Antibodies to HCoV-NL63 in Healthy Adults in Australia

  • Sean A. Lynch,
  • Kanta Subbarao,
  • Siddhartha Mahanty,
  • Bridget E. Barber and ,
  • Eileen V. Roulis,
  • Lia van der Hoek,
  • James S. McCarthy and
  • Kirsten M. Spann
  • + 3 authors+ 0 author

16 August 2021

The COVID-19 pandemic has highlighted the importance of understanding the immune response to seasonal human coronavirus (HCoV) infections such as HCoV-NL63, how existing neutralising antibodies to HCoV may modulate responses to SARS-CoV-2 infection,...

(This article belongs to the Collection Coronaviruses)
  • Article
  • Open Access
3 Citations
4,000 Views
18 Pages

Assessment of the Biological Impact of SARS-CoV-2 Genetic Variation Using an Authentic Virus Neutralisation Assay with Convalescent Plasma, Vaccinee Sera, and Standard Reagents

  • Naomi S. Coombes,
  • Kevin R. Bewley,
  • Yann Le Duff,
  • Matthew Hurley and ,
  • Lauren J. Smith,
  • Thomas M. Weldon,
  • Karen Osman,
  • Steven Pullan,
  • Neil Berry and
  • Simon G. P. Funnell
  • + 8 authors+ 3 authors

25 February 2023

In the summer of 2020, it became clear that the genetic composition of SARS-CoV-2 was changing rapidly. This was highlighted by the rapid emergence of the D614G mutation at that time. In the autumn of 2020, the project entitled “Agility”...

(This article belongs to the Topic Host Response against SARS-CoV-2 Infection: Implications for Diagnosis, Treatment and Vaccine Development)
  • Review
  • Open Access
9 Citations
7,835 Views
28 Pages

How Broadly Neutralising Antibodies Are Redefining Immunity to Influenza

  • Rebecca Steventon,
  • Lucas Stolle and
  • Craig Peter Thompson

7 January 2025

Recent avian influenza outbreaks have heightened global concern over viral threats with the potential to significantly impact human health. Influenza is particularly alarming due to its history of causing pandemics and zoonotic reservoirs. In respons...

(This article belongs to the Section Antibody Discovery and Engineering)
  • Article
  • Open Access
67 Citations
8,014 Views
18 Pages

Characterisation of SARS-CoV-2 Lentiviral Pseudotypes and Correlation between Pseudotype-Based Neutralisation Assays and Live Virus-Based Micro Neutralisation Assays

  • Inesa Hyseni,
  • Eleonora Molesti,
  • Linda Benincasa,
  • Pietro Piu and ,
  • Elisa Casa,
  • Nigel J Temperton,
  • Alessandro Manenti and
  • Emanuele Montomoli
  • + 3 authors+ 0 author

10 September 2020

The recent outbreak of a novel Coronavirus (SARS-CoV-2) and its rapid spread across the continents has generated an urgent need for assays to detect the neutralising activity of human sera or human monoclonal antibodies against SARS-CoV-2 spike prote...

(This article belongs to the Special Issue Antibody Responses to Viral Infections)
  • Article
  • Open Access
4 Citations
3,639 Views
15 Pages

The Application of Thermal Decomposition for Determination of Carbonate Acid-Neutralising Capacity for Improved Acid Mine Drainage Prediction

  • Andrea R. Gerson,
  • Paul Weber,
  • Roger St. C. Smart,
  • George Levay and ,
  • Mike Hutton-Ashkenny and
  • Rosalind Green
  • + 1 author+ 0 author

25 October 2021

This study developed an industry-applicable, thermal decomposition methodology for quantification of carbonate mineral acid neutralisation capacity (ANCtherm-carb) for waste rock, tailings, and other mined materials. Standard titration-based methods...

(This article belongs to the Section Mineral Processing and Extractive Metallurgy)
  • Article
  • Open Access
8 Citations
3,668 Views
11 Pages

Correlating IgG Levels with Neutralising Antibody Levels to Indicate Clinical Protection in Healthcare Workers at Risk during a Measles Outbreak

  • Siyuan Hu,
  • Nicola Logan,
  • Sarah Coleman,
  • Cariad Evans and ,
  • Brian J. Willett and
  • Margaret J. Hosie
  • + 1 author+ 0 author

4 August 2022

The rapid transmission of measles poses a great challenge for measles elimination. Thus, rapid testing is required to screen the health status in the population during measles outbreaks. A pseudotype-based virus neutralisation assay was used to measu...

(This article belongs to the Topic Infectious Diseases)
  • Communication
  • Open Access
5 Citations
3,876 Views
15 Pages

Taiwan Bat Lyssavirus: In Vitro and In Vivo Assessment of the Ability of Rabies Vaccine-Derived Antibodies to Neutralise a Novel Lyssavirus

  • Rebecca Shipley,
  • Edward Wright,
  • Samuel P. Smith,
  • David Selden and ,
  • Anthony R. Fooks and
  • Ashley C. Banyard
  • + 1 author+ 0 author

9 December 2022

Rabies is a neglected tropical disease. The prototype virus, the rabies virus, still causes tens of thousands of human fatalities annually. Rabies is one member of the genus Lyssavirus. The burden of other lyssaviruses is unclear. The continued emerg...

(This article belongs to the Special Issue Bat-Borne Viruses Research)
  • Article
  • Open Access
7 Citations
4,283 Views
15 Pages

Neutralising Effects of Different Antibodies on Clostridioides difficile Toxins TcdA and TcdB in a Translational Approach

  • Georg Csukovich,
  • Nina Kramer,
  • Barbara Pratscher,
  • Ivana Gotic and ,
  • Patricia Freund,
  • Rainer Hahn,
  • Gottfried Himmler,
  • Sabine Brandt and
  • Iwan Anton Burgener
  • + 4 authors+ 0 author

15 February 2023

Given the high prevalence of intestinal disease in humans and animals, there is a strong need for clinically relevant models recapitulating gastrointestinal systems, ideally replacing in vivo models in accordance with the principles of the 3R. We est...

(This article belongs to the Special Issue Organoids: The New 3D-Frontier to Model Different Diseases In Vitro)
  • Article
  • Open Access
1 Citations
2,032 Views
11 Pages

23 November 2023

For coagulation to be initiated, anticoagulant glycosaminoglycans (GAGs) such as heparins need to be neutralised to allow fibrin clot formation. Platelet activation triggers the release of several proteins that bind GAGs, including histidine-rich gly...

(This article belongs to the Special Issue Heparin, Heparan Sulfate and Heparanase in Health and Disease)
  • Article
  • Open Access
11 Citations
3,748 Views
8 Pages

Neutralising Antibodies against Enterovirus and Parechovirus in IVIG Reflect General Circulation: A Tool for Sero-Surveillance

  • Karen Couderé,
  • Karlijn van der Straten,
  • Lieke Brouwer,
  • Gerrit Koen and ,
  • Hetty van Eijk,
  • Dasja Pajkrt,
  • Jean-Luc Murk and
  • Katja C. Wolthers
  • + 3 authors+ 0 author

29 May 2021

Non-polio enteroviruses (NPEV) and parechoviruses (PeV) are widespread pathogens that cause significant morbidity. Surveillance is based on culturing or genotyping of virus strains found in clinical samples. Sero-surveillance, by measuring neutralisi...

(This article belongs to the Special Issue Surveillance for Polio and Non-polio Enteroviruses)
  • Article
  • Open Access
1,694 Views
17 Pages

Genomic Evolution of SARS-CoV-2 Variants of Concern Under In Vitro Neutralising Selection Pressure Following Two Doses of the Pfizer-BioNTech BNT162b2 COVID-19 Vaccine

  • Kerri Basile,
  • Jessica E. Agius,
  • Winkie Fong,
  • Kenneth McPhie and ,
  • Danny Ko,
  • Linda Hueston,
  • Connie Lam,
  • David Pham,
  • Sharon C.-A. Chen and
  • Rebecca J. Rockett
  • + 10 authors+ 5 authors

25 August 2025

We aimed to explore SARS-CoV-2 evolution during in vitro neutralisation using next generation sequencing, and to determine whether sera from individuals immunised with two doses of the Pfizer-BioNTech vaccine (BNT162b2) were as effective at neutralis...

(This article belongs to the Special Issue Emerging Concepts in SARS-CoV-2 Biology and Pathology 2.0)
  • Article
  • Open Access
3 Citations
3,877 Views
19 Pages

Specific Substitutions in Region V2 of gp120 env confer SHIV Neutralisation Resistance

  • Yalcin Pisil,
  • Zafer Yazici,
  • Hisatoshi Shida,
  • Shuzo Matsushita and
  • Tomoyuki Miura

A tier 2 SHIV-MK38 strain was obtained after two in vivo passages of tier 1 SHIV-MK1. SHIV-MK38#818, cloned from the MK38 strain, was neutralisation-resistant, like the parental MK38 strain, to SHIV-infected monkey plasma (MP), HIV-1-infected human p...

(This article belongs to the Section Viral Pathogens)
  • Article
  • Open Access
8 Citations
3,451 Views
10 Pages

Rapid Quantification of SARS-CoV-2 Neutralising Antibodies Using Time-Resolved Fluorescence Immunoassay

  • Gary R. McLean,
  • Yueke Zhang,
  • Rene Ndoyi,
  • Adam Martin and
  • Julian Winer

15 December 2022

The quantification of neutralising antibodies (NAb) for SARS-CoV-2 has become an important tool for monitoring protective immunity following infection or immunisation. In this study, we evaluated using World-Health-Organisation-standard immunoglobuli...

(This article belongs to the Special Issue Detection of SARS-CoV-2 Neutralizing Antibodies and Vaccine Development)
  • Article
  • Open Access
11 Citations
5,458 Views
13 Pages

Selective Persistence of HPV Cross-Neutralising Antibodies following Reduced-Dose HPV Vaccine Schedules

  • Zheng Quan Toh,
  • Jennie Kosasih,
  • Fiona M. Russell,
  • Rita Reyburn and ,
  • James Fong,
  • Evelyn Tuivaga,
  • Felisita T. Ratu,
  • Cattram D. Nguyen,
  • Silivia Matanitobua and
  • Paul V. Licciardi
  • + 10 authors+ 5 authors

28 November 2019

The duration of cross-neutralising antibody responses (cross-NAb) following HPV immunisation is unknown. We compared cross-NAb responses in cohort of girls who were either unimmunised or had received immunisation with one, two or three doses of 4vHPV...

  • Article
  • Open Access
21 Citations
3,930 Views
9 Pages

Optimised Non-Coding Regions of mRNA SARS-CoV-2 Vaccine CV2CoV Improves Homologous and Heterologous Neutralising Antibody Responses

  • Nicole Roth,
  • Jacob Schön,
  • Donata Hoffmann,
  • Moritz Thran and ,
  • Andreas Thess,
  • Stefan O. Mueller,
  • Benjamin Petsch and
  • Susanne Rauch
  • + 3 authors+ 0 author

4 August 2022

More than two years after the emergence of SARS-CoV-2, 33 COVID-19 vaccines, based on different platforms, have been approved in 197 countries. Novel variants that are less efficiently neutralised by antibodies raised against ancestral SARS-CoV-2 are...

(This article belongs to the Section Nucleic Acid (DNA and mRNA) Vaccines)
  • Article
  • Open Access
616 Views
13 Pages

Differential Binding and Neutralising Antibody Responses Across COVID-19 Severity in a Saudi Multicentre Cohort

  • Mariam M. AlEissa,
  • Nada Saleh,
  • Ahdab A. Alsaieedi,
  • Raghad A. AlQurashi and ,
  • Esraa A. Hawsa,
  • Muath ben Shaded,
  • Amer M. Alshehri,
  • Eyad Y. Abu Sarhan,
  • Osamah T. Khojah and
  • Abdullah M. Assiri
  • + 14 authors+ 9 authors

24 June 2026

Background: Humoral immune responses to SARS-CoV-2 are well documented, yet the immunopathogenic mechanisms distinguishing severe from critical disease remain incompletely defined, particularly in Middle Eastern populations. We investigated antibody...

(This article belongs to the Special Issue COVID-19 Complications and Co-Infections: 2nd Edition)
  • Article
  • Open Access
9 Citations
4,836 Views
21 Pages

Development of a Two-Component Nanoparticle Vaccine Displaying an HIV-1 Envelope Glycoprotein that Elicits Tier 2 Neutralising Antibodies

  • Kegomoditswe Malebo,
  • Jeremy Woodward,
  • Phindile Ximba,
  • Qiniso Mkhize and ,
  • Sanele Cingo,
  • Thandeka Moyo-Gwete,
  • Penny L. Moore,
  • Anna-Lise Williamson and
  • Rosamund Chapman
  • + 4 authors+ 0 author

18 September 2024

Despite treatment and other interventions, an effective prophylactic HIV vaccine is still an essential goal in the control of HIV. Inducing robust and long-lasting antibody responses is one of the main targets of an HIV vaccine. The delivery of HIV e...

(This article belongs to the Section Vaccine Design, Development, and Delivery)
  • Article
  • Open Access
1,538 Views
17 Pages

Subgenomic RNA and Limited Cross-Reactive Neutralising Antibodies Point to Potential Improvements in SARS-CoV-2 Clinical Handling

  • Carlos Davina-Nunez,
  • Sonia Perez-Castro,
  • Jorge Julio Cabrera-Alvargonzalez,
  • Elena Gonzalez-Alonso and ,
  • Sergio Silva-Bea,
  • Miriam Rodriguez-Perez,
  • Maria del Pilar Figueroa-Lamas,
  • Alexandre Perez-Gonzalez,
  • Victor del Campo and
  • Benito Regueiro-Garcia
  • + 7 authors+ 2 authors

The current clinical management of SARS-CoV-2 disease control and immunity may be not optimal anymore. Reverse transcription polymerase chain reaction (RT-PCR) of genomic viral RNA is broadly used for diagnosis, even though the virus may still be det...

(This article belongs to the Special Issue Viral Diseases of the Respiratory System—Molecular Mechanisms and Pathogenesis: 3rd Edition)
  • Article
  • Open Access
15 Citations
3,524 Views
13 Pages

Gender Neutralisation for Unbiased Speech Synthesising

  • Davit Rizhinashvili,
  • Abdallah Hussein Sham and
  • Gholamreza Anbarjafari

Machine learning can encode and amplify negative biases or stereotypes already present in humans, resulting in high-profile cases. There can be multiple sources encoding the negative bias in these algorithms, like errors from human labelling, inaccur...

(This article belongs to the Special Issue Human Emotion Recognition)
  • Article
  • Open Access
1,270 Views
18 Pages

17 March 2026

Background: Porcine epidemic diarrhoea virus (PEDV) is a highly contagious pathogen causing severe diarrhoea and high mortality in neonatal piglets. Methods: In this study, consensus sequences encoding the N-terminal domain of spike subunit 1 (S1-NTD...

(This article belongs to the Special Issue Novel Insights into Porcine Viral Diseases: Recombinant Strains and Immune Responses)
  • Article
  • Open Access
4 Citations
2,362 Views
14 Pages

Serological Response to COVID-19 Vaccination in Saudi Arabia: A Comparative Study of IgG and Neutralising Antibodies Across Vaccine Platforms

  • Mariam M. AlEissa,
  • Ahdab A. Alsaieedi,
  • Reema Alduaiji,
  • Fahad Almsned and ,
  • Yousif AlDossary,
  • Nada Saleh,
  • Raghad A. AlQurashi,
  • Esraa A. Hawsa,
  • Muath b Ben Shaded and
  • Abdullah M. Asiri
  • + 14 authors+ 9 authors

10 October 2025

Background: In the Kingdom of Saudi Arabia, various COVID-19 vaccines were administered during the pandemic. However, region-specific real-word comparative data on their immunogenicity remain limited. This study aimed to assess the serological respon...

(This article belongs to the Section COVID-19 Vaccines and Vaccination)
  • Article
  • Open Access
6 Citations
4,594 Views
11 Pages

Evaluation of a Pseudotyped Virus Neutralisation Test for the Measurement of Equine Influenza Virus-Neutralising Antibody Responses Induced by Vaccination and Infection

  • Rebecca Kinsley,
  • Stéphane Pronost,
  • Manuelle De Bock,
  • Nigel Temperton and ,
  • Janet M. Daly,
  • Romain Paillot and
  • Simon Scott
  • + 2 authors+ 0 author

21 August 2020

Equine influenza is a major respiratory disease of horses that is largely controlled by vaccination in some equine populations. Virus-neutralising antibodies, the mainstay of the protective immune response, are problematic in assaying for equine infl...

(This article belongs to the Section Veterinary Vaccines)
  • Article
  • Open Access
48 Citations
10,759 Views
17 Pages

Assessment of Immunogenicity and Neutralisation Efficacy of Viral-Vectored Vaccines Against Chikungunya Virus

  • César López-Camacho,
  • Young Chan Kim,
  • Joshua Blight,
  • Marcos Lazaro Moreli and ,
  • Eduardo Montoya-Diaz,
  • Juha T Huiskonen,
  • Beate Mareike Kümmerer and
  • Arturo Reyes-Sandoval
  • + 3 authors+ 0 author

3 April 2019

Chikungunya virus (CHIKV) has caused extensive outbreaks in several countries within the Americas, Asia, Oceanic/Pacific Islands, and Europe. In humans, CHIKV infections cause a debilitating disease with acute febrile illness and long-term polyarthra...

(This article belongs to the Special Issue Chikungunya Virus and (Re-) Emerging Alphaviruses)
  • Article
  • Open Access
6 Citations
2,289 Views
16 Pages

Older Age, a High Titre of Neutralising Antibodies and Therapy with Conventional DMARDs Are Associated with Protection from Breakthrough Infection in Rheumatoid Arthritis Patients after the Booster Dose of Anti-SARS-CoV-2 Vaccine

  • Andrea Picchianti-Diamanti,
  • Assunta Navarra,
  • Alessandra Aiello,
  • Bruno Laganà and ,
  • Gilda Cuzzi,
  • Andrea Salmi,
  • Valentina Vanini,
  • Fabrizio Maggi,
  • Silvia Meschi and
  • Delia Goletti
  • + 25 authors+ 20 authors

2 November 2023

Objectives: We aimed to analyse the incidence and severity of breakthrough infections (BIs) in rheumatoid arthritis (RA) patients after a COronaVIrus Disease 2019 (COVID-19) vaccination booster dose. Methods: We enrolled 194 RA patients and 1002 heal...

(This article belongs to the Section Vaccines, Clinical Advancement, and Associated Immunology)
  • Article
  • Open Access
2 Citations
3,567 Views
14 Pages

2 September 2025

The common krait (Bungarus caeruleus) and the endemic Sri Lankan krait (B. ceylonicus) are two species of krait responsible for envenomings in Sri Lanka that result in progressive neuromuscular paralysis. We characterised the in vitro neurotoxicity o...

(This article belongs to the Section Animal Venoms)
  • Article
  • Open Access
42 Citations
9,574 Views
12 Pages

19 August 2014

Medically important cases of snakebite in Europe are predominately caused by European vipers of the genus Vipera. The mainstay of snakebite therapy is polyclonal antibody therapy, referred to as antivenom. Here we investigate the capability of the mo...

(This article belongs to the Special Issue Antivenom and Venom Therapeutics)
  • Article
  • Open Access
12 Citations
4,921 Views
14 Pages

Analysis of Antibody Neutralisation Activity against SARS-CoV-2 Variants and Seasonal Human Coronaviruses NL63, HKU1, and 229E Induced by Three Different COVID-19 Vaccine Platforms

  • Diego Cantoni,
  • Gabriel Siracusano,
  • Martin Mayora-Neto,
  • Claudia Pastori and ,
  • Tobia Fantoni,
  • Spyros Lytras,
  • Cecilia Di Genova,
  • Joseph Hughes,
  • on behalf of the Ambulatorio Medico San Luca Villanuova Group and
  • Nigel Temperton
  • + 6 authors+ 1 author

27 December 2022

Coronaviruses infections, culminating in the recent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic beginning in 2019, have highlighted the importance of effective vaccines to induce an antibody response with cross-neutralizing...

(This article belongs to the Section COVID-19 Vaccines and Vaccination)
  • Article
  • Open Access
2 Citations
4,077 Views
18 Pages

Characterisation of the Antibody Response in Sinopharm (BBIBP-CorV) Recipients and COVID-19 Convalescent Sera from the Republic of Moldova

  • Mariana Ulinici,
  • Alen Suljič,
  • Monica Poggianella,
  • Rafaela Milan Bonotto and ,
  • Katarina Resman Rus,
  • Angela Paraschiv,
  • Amedeo Marco Bonetti,
  • Mihail Todiras,
  • Alexandru Corlateanu and
  • Alessandro Marcello
  • + 8 authors+ 3 authors

13 March 2023

The early availability of effective vaccines against SARS-CoV-2, the aetiologic cause of COVID-19, has been at the cornerstone of the global recovery from the pandemic. This study aimed to assess the antispike RBD IgG antibody titres and neutralisati...

(This article belongs to the Special Issue Antibody Response of Vaccines to SARS-CoV-2)
  • Article
  • Open Access
9 Citations
7,004 Views
27 Pages

31 March 2022

The foundational study for this article asked: how do survivors of clergy sexual misconduct against adults (CSMAA) in the Roman Catholic Church (RCC) describe and understand their experiences of reporting that misconduct to Roman Catholic Church auth...

(This article belongs to the Special Issue Sexual and Spiritual Violence against Adult Men and Women in the Catholic Church)
  • Article
  • Open Access
20 Citations
4,454 Views
19 Pages

Mapping of Recognition Sites of Monoclonal Antibodies Responsible for the Inhibition of Pneumolysin Functional Activity

  • Indre Kucinskaite-Kodze,
  • Martynas Simanavicius,
  • Justas Dapkunas,
  • Milda Pleckaityte and
  • Aurelija Zvirbliene

8 July 2020

The pathogenicity of many bacteria, including Streptococcus pneumoniae, depends on pore-forming toxins (PFTs) that cause host cell lysis by forming large pores in cholesterol-containing cell membranes. Therefore, PFTs-neutralising antibodies may prov...

  • Article
  • Open Access
8 Citations
5,387 Views
30 Pages

A Global Collaborative Comparison of SARS-CoV-2 Antigenicity Across 15 Laboratories

  • Polina Brangel,
  • Sina Tureli,
  • Barbara Mühlemann,
  • Nicole Liechti and ,
  • Daniel Zysset,
  • Olivier Engler,
  • Isabel Hunger-Glaser,
  • Ioana Ghiga,
  • Giada Mattiuzzo and
  • Lorenzo Subissi
  • + 51 authors+ 46 authors

18 December 2024

Setting up a global SARS-CoV-2 surveillance system requires an understanding of how virus isolation and propagation practices, use of animal or human sera, and different neutralisation assay platforms influence assessment of SARS-CoV-2 antigenicity....

(This article belongs to the Special Issue Host Cell-Virus Interaction, 4th Edition)
  • Review
  • Open Access
31 Citations
6,746 Views
21 Pages

22 October 2022

Snakebite envenoming is a neglected tropical disease (NTD) that results from the injection of snake venom of a venomous snake into animals and humans. In Africa (mainly in sub-Saharan Africa), over 100,000 envenomings and over 10,000 deaths per annum...

  • Review
  • Open Access
23 Citations
8,910 Views
12 Pages

10 August 2018

Initial attempts to develop monoclonal antibodies as therapeutics to resolve influenza infections focused mainly on searching for antibodies with the potential to neutralise the virus in vitro with classical haemagglutination inhibition and microneut...

of 9